Enveda secures $55 million in Series B extension to integrate ancient remedies with AI for drug discovery.
Amount Raised
$55 Million
Round Type
Series B
BoulderOtherBiotechnologyInvestors
Description
Enveda announced a $55 million Series B extension from new investors to integrate ancient remedies with AI to discover new drugs. The latest funding round brings Enveda’s total capital to $230 million and involves contributions from both new and existing investors.
Quick answer
Enveda Therapeutics, Inc. raised $55 Million in a Series B round, dated June 14, 2024. Investors: JAZZ Venture Partners, Level Ventures, Fpv, True Ventures, Kinnevik, Lingotto Investment Fund, Premji Invest and The Nature Conservancy. Enveda Therapeutics, Inc. is based in Boulder, Colorado, United States.
- How much did Enveda Therapeutics, Inc. raise?
- Enveda Therapeutics, Inc. raised $55 Million in a Series B round on June 14, 2024.
- Who invested in Enveda Therapeutics, Inc?
- JAZZ Venture Partners, Level Ventures, Fpv, True Ventures, Kinnevik, Lingotto Investment Fund, Premji Invest and The Nature Conservancy are named as investors in this round.
- What does Enveda Therapeutics, Inc. do?
- Enveda Biosciences is a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery.
- Where is Enveda Therapeutics, Inc. based and how big is it?
- Enveda Therapeutics, Inc. is based in Boulder, Colorado, United States. Fundz records about 387 employees.
- Who are the decision-makers at Enveda Therapeutics, Inc?
- Fundz holds 5 contacts at Enveda Therapeutics, Inc., including the Associate Director Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Enveda Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Melt&Marble raised $3M (Funding Round) on July 29, 2024.
- Chemomab Therapeutics Ltd raised $10M on July 29, 2024.
- Schrodinger, Inc. raised $10M (Grant) on July 29, 2024.
- Spear Bio raised $45M (Series A) on July 29, 2024.
- CEL-SCI Corporation raised $11M (Debt Financing) on July 29, 2024.
- LinusBio raised $6.1M on July 29, 2024.
Who to call at Enveda Therapeutics, Inc., and when
A new round usually means Enveda Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Enveda Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enveda Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enveda Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enveda Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEnveda Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.